Emixef is an orally administered, third-generation cephalosporin antibiotic with strong in-vitro bactericidal activity against a broad range of Gram-positive and Gram-negative organisms. It is indicated for the treatment of acute infections caused by susceptible pathogens, particularly where resistance to commonly used antibiotics is suspected or where treatment failure may pose significant risk.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Cefixime is a third-generation semi-synthetic cephalosporin intended for oral use. It exerts its bactericidal effect by inhibiting bacterial cell wall synthesis, leading to bacterial death. Due to its stability against β-lactamase enzymes, many organisms resistant to penicillins and earlier cephalosporins remain susceptible to cefixime. Oral absorption is approximately 40–50%, and food intake does not significantly affect its bioavailability.
Food does not significantly influence absorption.
The usual treatment duration is 7 days, which may be extended up to 14 days if clinically required.
200–400 mg daily, administered as a single dose or in two divided doses, depending on infection severity
Same dosage as adults
Renal function should be assessed, with dose adjustment in severe renal impairment
8 mg/kg/day, given once daily or in two divided doses
Suggested suspension dosing:
6 months–1 year: 3.75 ml daily
1–4 years: 5 ml daily
5–10 years: 10 ml daily
Typhoid fever (children):
5 mg/kg body weight twice daily for 10–14 days
Children weighing >50 kg or aged ≥10 years should receive adult dosing.
⚠️ Safety and efficacy have not been established in children below 6 months of age.
Creatinine clearance ≥20 ml/min: Normal dosing may be used
Creatinine clearance <20 ml/min: Maximum dose should not exceed 200 mg once daily
Patients on hemodialysis or peritoneal dialysis should follow the same dosing recommendations as those with creatinine clearance <20 ml/min
Emixef is generally well tolerated, with most adverse reactions being mild and self-limiting.
Diarrhea (more common with higher doses)
Nausea
Abdominal pain
Dyspepsia
Vomiting
Flatulence
Rarely, pseudomembranous colitis
Headache
Dizziness
Rash
Pruritus
Urticaria
Drug fever
Arthralgia
These typically resolve upon discontinuation.
Thrombocytopenia
Leukopenia
Eosinophilia
Mild, transient elevations in liver and renal function tests
Genital pruritus
Vaginitis
As with other cephalosporins, cefixime may cause prolongation of prothrombin time in some patients. Caution is advised when administered concurrently with anticoagulant therapy.
Known hypersensitivity to cephalosporin antibiotics
Adequate and well-controlled studies in pregnant women are lacking. Cefixime should be used during pregnancy only if clearly necessary. It is not known whether cefixime is excreted in human breast milk; therefore, caution is advised when administered to nursing mothers.
Use with caution in patients with a history of drug hypersensitivity
Partial cross-reactivity may occur in penicillin-sensitive patients
Discontinue immediately if allergic reactions occur
Use cautiously in patients with severe renal impairment
Broad-spectrum antibiotic use may lead to Clostridium difficile–associated diarrhea
Store below 30°C, protected from light and moisture.
Keep out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.